Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells
2014 · Leukemia · 34 citations
https://doi.org/10.1038/leu.2014.182
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.0K
Citations
14
h-index
15
i10-index
Yao‐Te Hsieh is an academic researcher from AstraZeneca (South Korea). The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Innovative Microfluidic and Catalytic Techniques Innovation & 3D Printing in Biomedical Research. The author has an h-index of 14, co-authored 45 publications.
https://doi.org/10.1038/leu.2014.182
https://doi.org/10.1038/s43016-023-00705-0
Click to start Chat